Eurofins Scientific S.E. 

$11.99
295
+$1.99+19.9% Tuesday 20:37

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

29JulExpected
Q4 2025
Next
1.48
1.73
1.99
2.24
Expected EPS
2.2447104
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ERRFY. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap174.37B
Thermo Fisher Scientific Inc. offers similar analytical services and laboratory equipment, directly competing in the life sciences and diagnostics market.
Danaher
DHR
Mkt Cap123.97B
Danaher Corporation operates in the life sciences, diagnostics, and environmental industries, offering products and services that overlap with Eurofins' offerings.
Agilent Technologies
A
Mkt Cap32.36B
Agilent Technologies, Inc. provides instruments, services, consumables, applications, and expertise in the life sciences and applied chemical markets.
Waters
WAT
Mkt Cap30.15B
Waters Corporation produces analytical instruments and software that compete in the pharmaceutical, life science, biochemical, industrial, and environmental industries.
Bio-Rad Laboratories
BIO
Mkt Cap6.93B
Bio-Rad Laboratories, Inc. offers products and services in the life science research and clinical diagnostics markets, competing with Eurofins in several sectors.
Bruker
BRKR
Mkt Cap5.6B
Bruker Corporation designs and manufactures scientific instruments and analytical and diagnostic solutions, competing in the life science and analytical instruments sector.
Mettler-Toledo International
MTD
Mkt Cap25.66B
Mettler-Toledo International Inc. specializes in precision instruments for research, scientific, and quality control labs, competing in the analytical and diagnostic equipment sector.
Resmed
RMD
Mkt Cap29.87B
ResMed Inc. specializes in medical devices and cloud-based software applications for the diagnostics and management of sleep apnea, chronic obstructive pulmonary disease, and other chronic diseases, indirectly competing in the broader healthcare diagnostics market.
Guardant Health
GH
Mkt Cap11.61B
Guardant Health, Inc. focuses on liquid biopsies and cancer diagnostics, competing in the specialized diagnostics and genomic services market that Eurofins also serves.

About

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of approximately 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agro-science, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, and healthcare and cosmetics; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include product compliance and audit, testing, certifications and approvals, inspections, training courses, and digital media and cyber security for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, labelling, law, heavy metals, identity preservation, mealtime, molecular and microbiology, mycotoxins, nutritional analyses, organic containments, packaging/migration, radioactivity, rapidest, sensorsy and consumer research, trainings, veterinary drug residues, and vitamins services. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and technologies services. It operates approximately 900 laboratories in 54 countries. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.
Show more...
CEO
Dr. Gilles G. Martin Ph.D.
Employees
61000
Country
Luxembourg
ISIN
US29873U1060

Listings

0 Comments

Share your thoughts

FAQ

What is Eurofins Scientific S.E. stock price today?
The current price of ERRFY is $11.99 USD — it has increased by +19.9% in the past 24 hours. Watch Eurofins Scientific S.E. stock price performance more closely on the chart.
What is Eurofins Scientific S.E. stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Eurofins Scientific S.E. stocks are traded under the ticker ERRFY.
When is the next Eurofins Scientific S.E. earnings date?
Eurofins Scientific S.E. is going to release the next earnings report on July 29, 2026.
What were Eurofins Scientific S.E. earnings last quarter?
ERRFY earnings for the last quarter are 1.5 USD per share, whereas the estimation was 1.48 USD resulting in a +1.59% surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does Eurofins Scientific S.E. have?
As of May 06, 2026, the company has 61,000 employees.
In which sector is Eurofins Scientific S.E. located?
Eurofins Scientific S.E. operates in the Health & Wellness sector.
When did Eurofins Scientific S.E. complete a stock split?
The last stock split for Eurofins Scientific S.E. was on December 02, 2020 with a ratio of 2.5:1.
Where is Eurofins Scientific S.E. headquartered?
Eurofins Scientific S.E. is headquartered in Luxembourg City, Luxembourg.